(Q39608973)

1 July 2019

title

Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells (English)

1 reference

1 July 2019

1 reference

Amit Khanna

1

1 reference

1 July 2019

Kulandaivelu Mahalingam

series ordinal

2

1 reference

1 July 2019

Debarshi Chakrabarti

series ordinal

3

1 reference

1 July 2019

Giridharan Periyasamy

series ordinal

4

1 reference

1 July 2019

publication date

27 December 2010

1 reference

1 July 2019

Cellular & Molecular Biology Letters

published in

1 reference

1 July 2019

volume

16

1 reference

1 July 2019

issue

1

1 reference

1 July 2019

page(s)

101-113

1 reference

1 July 2019

https://scigraph.springernature.com/pub.10.2478/s11658-010-0043-z

exact match

0 references

cites work

Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-010-0043-Z

Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.

21 January 2018

1 reference

12 December 2020

The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26

1 reference

12 December 2020

Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers

1 reference

12 December 2020

Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

1 reference

12 December 2020

Stromal expression of c-Ets1 transcription factor correlates with tumor invasion

1 reference

12 December 2020

Role of the transcription factor Ets-1 in cisplatin resistance.

1 reference

12 December 2020

Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation

1 reference

12 December 2020

Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer.

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3.

1 reference

12 December 2020

10.2478/S11658-010-0043-Z

Identifiers

DOI

1 reference

1 July 2019

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.2478/s11658-010-0043-z

PMC publication ID

6276009

1 reference

1 July 2019

PubMed publication ID

21225469

1 reference

1 July 2019